260 related articles for article (PubMed ID: 12904571)
1. Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT.
Long J; Matsuura I; He D; Wang G; Shuai K; Liu F
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9791-6. PubMed ID: 12904571
[TBL] [Abstract][Full Text] [Related]
2. Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3).
Long J; Wang G; Matsuura I; He D; Liu F
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):99-104. PubMed ID: 14691252
[TBL] [Abstract][Full Text] [Related]
3. Regulation of transforming growth factor-beta signaling by protein inhibitor of activated STAT, PIASy through Smad3.
Imoto S; Sugiyama K; Muromoto R; Sato N; Yamamoto T; Matsuda T
J Biol Chem; 2003 Sep; 278(36):34253-8. PubMed ID: 12815042
[TBL] [Abstract][Full Text] [Related]
4. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling.
Lee PS; Chang C; Liu D; Derynck R
J Biol Chem; 2003 Jul; 278(30):27853-63. PubMed ID: 12740389
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein.
Yingling JM; Datto MB; Wong C; Frederick JP; Liberati NT; Wang XF
Mol Cell Biol; 1997 Dec; 17(12):7019-28. PubMed ID: 9372933
[TBL] [Abstract][Full Text] [Related]
6. Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation.
Kurisaki K; Kurisaki A; Valcourt U; Terentiev AA; Pardali K; Ten Dijke P; Heldin CH; Ericsson J; Moustakas A
Mol Cell Biol; 2003 Jul; 23(13):4494-510. PubMed ID: 12808092
[TBL] [Abstract][Full Text] [Related]
7. The RING domain of PIASy is involved in the suppression of bone morphogenetic protein-signaling pathway.
Imoto S; Sugiyama K; Yamamoto T; Matsuda T
Biochem Biophys Res Commun; 2004 Jun; 319(1):275-82. PubMed ID: 15158472
[TBL] [Abstract][Full Text] [Related]
8. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
[TBL] [Abstract][Full Text] [Related]
9. A novel E1A-like inhibitor of differentiation (EID) family member, EID-2, suppresses transforming growth factor (TGF)-beta signaling by blocking TGF-beta-induced formation of Smad3-Smad4 complexes.
Lee HJ; Lee JK; Miyake S; Kim SJ
J Biol Chem; 2004 Jan; 279(4):2666-72. PubMed ID: 14612439
[TBL] [Abstract][Full Text] [Related]
10. Smad4/DPC4 and Smad3 mediate transforming growth factor-beta (TGF-beta) signaling through direct binding to a novel TGF-beta-responsive element in the human plasminogen activator inhibitor-1 promoter.
Song CZ; Siok TE; Gelehrter TD
J Biol Chem; 1998 Nov; 273(45):29287-90. PubMed ID: 9792626
[TBL] [Abstract][Full Text] [Related]
11. Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta.
Pardali K; Kurisaki A; Morén A; ten Dijke P; Kardassis D; Moustakas A
J Biol Chem; 2000 Sep; 275(38):29244-56. PubMed ID: 10878024
[TBL] [Abstract][Full Text] [Related]
12. Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta.
Chen SJ; Yuan W; Lo S; Trojanowska M; Varga J
J Cell Physiol; 2000 Jun; 183(3):381-92. PubMed ID: 10797313
[TBL] [Abstract][Full Text] [Related]
13. TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling.
Felici A; Wurthner JU; Parks WT; Giam LR; Reiss M; Karpova TS; McNally JG; Roberts AB
EMBO J; 2003 Sep; 22(17):4465-77. PubMed ID: 12941698
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
Yuan W; Varga J
J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
[TBL] [Abstract][Full Text] [Related]
15. Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor beta-induced smad-dependent transcriptional activation.
Stroschein SL; Wang W; Luo K
J Biol Chem; 1999 Apr; 274(14):9431-41. PubMed ID: 10092624
[TBL] [Abstract][Full Text] [Related]
16. CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription.
Li L; Xin H; Xu X; Huang M; Zhang X; Chen Y; Zhang S; Fu XY; Chang Z
Mol Cell Biol; 2004 Jan; 24(2):856-64. PubMed ID: 14701756
[TBL] [Abstract][Full Text] [Related]
17. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.
Zhang Y; Musci T; Derynck R
Curr Biol; 1997 Apr; 7(4):270-6. PubMed ID: 9094310
[TBL] [Abstract][Full Text] [Related]
18. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
Feng XH; Lin X; Derynck R
EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
[TBL] [Abstract][Full Text] [Related]
19. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene.
Dennler S; Itoh S; Vivien D; ten Dijke P; Huet S; Gauthier JM
EMBO J; 1998 Jun; 17(11):3091-100. PubMed ID: 9606191
[TBL] [Abstract][Full Text] [Related]
20. PIASy inhibits LRH-1-dependent CYP11A1 expression by competing for SRC-1 binding.
Hsieh HT; Wang CH; Wu ML; Yang FM; Tai YC; Hu MC
Biochem J; 2009 Apr; 419(1):201-9. PubMed ID: 19067654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
